HCL Tech: Strong Q1 masks guidance credibility hangover
Revenue and profit beat, record bookings, AI surge — but a mid-year guidance cut and Phase 2 backtrack raise doubts.
The numbers
- Revenue ₹34,579 cr, up 14% YoY, net profit ₹4,624 cr, up 20% YoY — clean beat.
- Board declared ₹12 interim dividend for FY27, reflecting cash confidence.
- Record $2.4B total contract value bookings in Q1, highest ever first quarter.
- Advanced AI revenue $172M, up 62% YoY and 10.3% QoQ.
- No exceptional items in the quarter.
Management's story
- FY27 organic revenue growth guided 1-4% with EBIT margin 17.5-18.5%, including 40-50 bps restructuring hit.
- Mega deal revenue negligible in FY27; steady state expected April 2027.
- Restructuring and AI efficiencies boosted margins 39 bps QoQ to 16.9% (adjusted 17.5%).
- ₹3,500 cr data center capex and $150M Sarvam AI investment funded via cash flow.
- Refused to guide on FY28 margin targets or provide revenue conversion timeline for mega deal.
“We're currently in preliminary planning phases for Phase 2 and will provide timeline updates next quarter.”
— HCL Technologies management, Jan 2026 call
Where they diverge
The reported quarter is unambiguously strong: revenue up 14%, profit up 20%, record bookings, AI revenue surging 62%. Yet management’s narrative dances around an infrastructure of falling credibility. The FY26 guidance was cut from 8-10% to 4-4.5% revenue growth and 18-20% to 17-18% margin mid-year, with no adequate explanation. A Phase 2 project went from 'fully funded and ahead of schedule' (Oct 2025) to 'preliminary planning' (Jan 2026). The FY27 guidance of 1-4% growth is low enough to beat, but until management rebuilds track record, each number carries a discount.
The full read
HCL Tech delivered a technically strong Q1: revenue up 14%, profit up 20%, record $2.4B bookings, AI revenue surging 62% to $172M. The board added a ₹12 interim dividend. But the call reveals a guidance credibility problem that these headline numbers don't fix. In FY26, management slashed revenue growth guidance from 8-10% to 4-4.5% and EBIT margin from 18-20% to 17-18% mid-year, never fully explaining why. Worse, a key Phase 2 project that was 'fully funded and ahead of schedule' in October 2025 became 'preliminary planning' by January 2026. For FY27, management guided organic growth of 1-4% and margin of 17.5-18.5% including restructuring costs — low enough to beat, but deliberately so. The mega deal that drove optimism will contribute negligible revenue until April 2027. Management also refused to guide on FY28 margins. Strong as this quarter is, the divergence between current performance and forward narrative leaves investors needing more than one quarter of clean numbers to restore trust in guidance.
What we're watching
- Phase 2 timeline update: management promised clarity next quarter after the Jan 2026 downgrade to 'preliminary planning'.
- E&R segment trajectory: declined 3.7% QoQ due to telecom and US healthcare cuts, likely to persist.
- Data center and Sarvam execution: capex phasing and return on equity impact uncertain; watch for FY28 margin guidance refusal to resolve.